Cargando…

Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma

The pathogenesis of hepatocellular carcinoma (HCC) can be divided into viral infection (VIR) and nonviral (NVIR) infection. Two types of HCC performed different tumor immune microenvironment (TIME) which directly affected prognosis of HCC. This study aimed to identify an effective 2 types of HCC pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Hong, Song, Shanglin, Tian, Yunling, Qi, Lei, Gao, Haihong, Yuan, Lingyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052083/ https://www.ncbi.nlm.nih.gov/pubmed/33847635 http://dx.doi.org/10.1097/MD.0000000000025374

Ejemplares similares

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Prognostic significance and immune infiltration of microenvironment-related signatures in pancreatic cancer
por: Lu, Qian, et al.
Publicado: (2021)

The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma
por: Yang, Sen, et al.
Publicado: (2023)

Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma
por: Kgatle, Mankgopo M., et al.
Publicado: (2016)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

Identification of an 11-lncRNA signature with high performance for predicting the prognosis of hepatocellular carcinoma using bioinformatics analysis
por: Wang, Anmei, et al.
Publicado: (2021)

Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma
por: Yu, Youlin, et al.
Publicado: (2023)

Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma
por: Deng, Benyuan, et al.
Publicado: (2020)

Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma: A Review
por: Bu, Fan, et al.
Publicado: (2022)

Intelectin-1 is a novel prognostic biomarker for hepatocellular carcinoma
por: Li, Jiang, et al.
Publicado: (2023)

The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma: A meta-analysis
por: Sun, Chi, et al.
Publicado: (2017)

TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma
por: Lu, Qin, et al.
Publicado: (2023)

The texture of collagen in the microenvironments of Merkel cell carcinoma
por: Laurito, Tiago Luders, et al.
Publicado: (2021)

Impact of intraoperative allogenic and autologous transfusion on immune function and prognosis in patients with hepatocellular carcinoma
por: Gong, Youwei, et al.
Publicado: (2020)

Statin-Based Palliative Therapy for Hepatocellular Carcinoma
por: Shao, Joni Yu-Hsuan, et al.
Publicado: (2015)

Cuproptosis-associated genes and immune microenvironment characterization in breast cancer
por: Shen, Lijuan, et al.
Publicado: (2022)

Clinical significance of down-regulated HINT2 in hepatocellular carcinoma
por: Zhou, Dong-Kai, et al.
Publicado: (2019)

Prognostic role of urokinase plasminogen activator in hepatocellular carcinoma: A protocol for systematic review and meta analysis
por: Tao, Pengxian, et al.
Publicado: (2020)

Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma
por: Du, Zhongxiang, et al.
Publicado: (2023)

Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients
por: Bai, Zhenzi, et al.
Publicado: (2020)

A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets
por: Qin, Yuan-Yuan, et al.
Publicado: (2023)

High expression of HILPDA is an adverse prognostic prognostic factor in hepatocellular carcinoma
por: Wang, Xiao, et al.
Publicado: (2023)

Relationship between a 7-mRNA signature of the pancreatic adenocarcinoma microenvironment and patient prognosis (a STROBE-compliant article)
por: He, Qing-lin, et al.
Publicado: (2020)

Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients
por: Wu, Li-Li, et al.
Publicado: (2016)

Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis
por: Sun, Quanquan, et al.
Publicado: (2020)

Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2021)

Efficacy and safety of immune checkpoint inhibitors combined anti-angiogenic therapy in patients with unresectable hepatocellular carcinoma: A meta-analysis
por: Xian, Feng, et al.
Publicado: (2022)

A seven-m(6)A regulator-related CpG site-based prognostic signature for endometrial carcinoma
por: Zhang, Xiang, et al.
Publicado: (2021)

Screening and identification of key genes between liver hepatocellular carcinoma (LIHC) and cholangiocarcinoma (CHOL) by bioinformatic analysis
por: Kang, Xindan, et al.
Publicado: (2020)

Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk
por: Li, Hong-Guang, et al.
Publicado: (2015)

The exploration of new biomarkers for oral cancer through the ceRNA network and immune microenvironment analysis
por: Ma, Sai, et al.
Publicado: (2022)

Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients
por: Li, Zhehong, et al.
Publicado: (2022)

Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis
por: Lu, Shan, et al.
Publicado: (2023)

Recurrence of Hepatocellular Carcinoma With Epithelial–Mesenchymal Transition After Spontaneous Regression: A Case Report
por: Yang, Shi-zhong, et al.
Publicado: (2015)

Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study
por: Wang, Lei, et al.
Publicado: (2023)

Efficacy of treatment regimens for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery
por: Shen, Tao, et al.
Publicado: (2017)

Oxeiptosis core genes and their multi-omics analysis in hepatocellular carcinoma
por: Lin, Sen, et al.
Publicado: (2023)

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy
por: Jiang, Bei-ge, et al.
Publicado: (2015)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cs7sohlqfto6034luvpvjgihjb